Operaciones ADMA Biologics, Inc. - ADMA CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.0402 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024874% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.002651% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 3.1304 |
Abrir* | 3.1902 |
Cambio de 1 año* | 79.22% |
Rango del día* | 3.1902 - 3.3298 |
Rango de 52 semanas | 1.43-3.98 |
Volumen medio (10 días) | 3.03M |
Volumen medio (3 meses) | 51.51M |
Capitalización de mercado | 726.45M |
Ratio P/E | -100.00K |
Acciones en circulación | 222.16M |
Ingresos | 154.08M |
EPS | -0.33 |
Dividendo (Rendimiento %) | N/A |
Beta | 0.92 |
Próxima fecha de resultados | May 9, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 30, 2023 | 3.1304 | -0.0997 | -3.09% | 3.2301 | 3.2999 | 3.1204 |
Mar 29, 2023 | 3.2501 | 0.0700 | 2.20% | 3.1801 | 3.2600 | 3.1801 |
Mar 28, 2023 | 3.1803 | -0.0996 | -3.04% | 3.2799 | 3.3597 | 3.1703 |
Mar 27, 2023 | 3.2999 | -0.0199 | -0.60% | 3.3198 | 3.4495 | 3.2899 |
Mar 24, 2023 | 3.3198 | 0.0299 | 0.91% | 3.2899 | 3.4096 | 3.2301 |
Mar 23, 2023 | 3.1105 | 0.0997 | 3.31% | 3.0108 | 3.1204 | 3.0107 |
Mar 22, 2023 | 2.9809 | -0.0697 | -2.28% | 3.0506 | 3.0905 | 2.9809 |
Mar 21, 2023 | 3.0706 | 0.0300 | 0.99% | 3.0406 | 3.1703 | 3.0406 |
Mar 20, 2023 | 3.0507 | -0.0299 | -0.97% | 3.0806 | 3.1005 | 2.9310 |
Mar 17, 2023 | 3.0606 | -0.0298 | -0.96% | 3.0904 | 3.1204 | 3.0207 |
Mar 16, 2023 | 3.1105 | 0.0300 | 0.97% | 3.0805 | 3.1703 | 3.0506 |
Mar 15, 2023 | 3.1105 | 0.0001 | 0.00% | 3.1104 | 3.1902 | 3.0806 |
Mar 14, 2023 | 3.2002 | -0.0099 | -0.31% | 3.2101 | 3.2600 | 3.1603 |
Mar 13, 2023 | 3.1803 | 0.1696 | 5.63% | 3.0107 | 3.2201 | 3.0008 |
Mar 10, 2023 | 3.0806 | -0.1594 | -4.92% | 3.2400 | 3.2600 | 3.0307 |
Mar 9, 2023 | 3.2600 | -0.1496 | -4.39% | 3.4096 | 3.4395 | 3.2102 |
Mar 8, 2023 | 3.3896 | 0.0100 | 0.30% | 3.3796 | 3.4495 | 3.3497 |
Mar 7, 2023 | 3.3797 | 0.0200 | 0.60% | 3.3597 | 3.4495 | 3.2998 |
Mar 6, 2023 | 3.3398 | -0.0697 | -2.04% | 3.4095 | 3.4295 | 3.2999 |
Mar 3, 2023 | 3.3996 | -0.0897 | -2.57% | 3.4893 | 3.4893 | 3.3697 |
ADMA Biologics, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos totales | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
Ingresos | 80.9426 | 42.2198 | 29.3491 | 16.9853 | 22.7606 |
Coste de los ingresos, total | 79.7693 | 61.2914 | 39.5042 | 42.1946 | 29.1643 |
Beneficio bruto | 1.17329 | -19.0716 | -10.1552 | -25.2094 | -6.40376 |
Gastos totales de explotación | 139.316 | 106.143 | 80.7359 | 77.2742 | 63.2808 |
Gastos de venta/general/administración Gastos, total | 55.1856 | 39.2209 | 28.0804 | 30.3085 | 24.5966 |
Investigación y desarrollo | 3.64606 | 5.90701 | 2.34385 | 3.92612 | 6.22959 |
Gastos (ingresos) extraordinarios | 0 | -0.9918 | 9.9625 | 0 | 2.05561 |
Ingresos de explotación | -58.3737 | -63.9231 | -51.3868 | -60.2889 | -40.5202 |
Ingresos por intereses (gastos), netos No operativos | -13.0223 | -11.6969 | -8.19259 | -5.32738 | -3.22862 |
Otros, netos | -0.25158 | -0.12853 | -0.22732 | -0.12712 | -0.01014 |
Ingresos netos antes de impuestos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Ingresos netos después de impuestos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Beneficio neto antes de partidas extra. Elementos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Ingresos netos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Beneficio neto diluido | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Promedio ponderado de acciones diluidas | 139.579 | 86.1451 | 54.3481 | 45.1889 | 22.896 |
BPA diluido sin partidas extraordinarias | -0.51331 | -0.87931 | -0.88833 | -1.45486 | -1.9112 |
BPA normalizado diluido | -0.51331 | -0.89083 | -0.91713 | -1.45486 | -1.82142 |
Depreciation / Amortization | 0.71535 | 0.71535 | 0.84494 | 0.84494 | 1.23467 |
Total de partidas extraordinarias | 0 | ||||
Gain (Loss) on Sale of Assets | 0 | 11.5274 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Ingresos totales | 41.0901 | 33.905 | 29.1031 | 26.3829 | 20.6805 |
Ingresos | 41.0901 | 33.905 | 29.1031 | 26.3829 | 20.6805 |
Coste de los ingresos, total | 31.4335 | 26.1356 | 25.441 | 22.8714 | 20.2952 |
Beneficio bruto | 9.65664 | 7.7694 | 3.66204 | 3.51149 | 0.38534 |
Gastos totales de explotación | 50.4069 | 43.0798 | 50.5881 | 39.5741 | 35.1176 |
Gastos de venta/general/administración Gastos, total | 17.7526 | 15.8919 | 17.6742 | 15.7948 | 13.873 |
Investigación y desarrollo | 1.04195 | 0.87339 | 0.62411 | 0.72899 | 0.77056 |
Depreciation / Amortization | 0.17884 | 0.17884 | 0.17884 | 0.17884 | 0.17884 |
Ingresos de explotación | -9.31673 | -9.17474 | -21.485 | -13.1912 | -14.4371 |
Ingresos por intereses (gastos), netos No operativos | -5.57313 | -4.57075 | -3.35597 | -3.31343 | -3.29442 |
Otros, netos | -0.00964 | -0.01942 | -0.16688 | -0.1448 | 0.01855 |
Ingresos netos antes de impuestos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Ingresos netos después de impuestos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Beneficio neto antes de partidas extra. Elementos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Ingresos netos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Beneficio neto diluido | -14.8995 | -13.7649 | -25.0079 | -16.6494 | -17.7129 |
Promedio ponderado de acciones diluidas | 196.384 | 196.353 | 195.872 | 181.267 | 133.77 |
BPA diluido sin partidas extraordinarias | -0.07587 | -0.0701 | -0.12767 | -0.09185 | -0.13241 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.07587 | -0.0701 | -0.09362 | -0.09185 | -0.13241 |
Gastos (ingresos) extraordinarios | 0 | 0 | 6.66994 | 0 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Activo Corriente | 208.729 | 153.741 | 85.8204 | 44.5296 | 62.3416 |
Efectivo e inversiones a corto plazo | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
Efectivo y Equivalentes | 51.0891 | 55.9212 | 26.7521 | 22.7549 | 43.1076 |
Inversiones a corto plazo | |||||
Total deudores, neto | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
Accounts Receivable - Trade, Net | 28.5769 | 13.2373 | 3.46992 | 1.39244 | 3.88015 |
Total Inventory | 124.724 | 81.5356 | 53.0647 | 18.6162 | 12.6282 |
Prepaid Expenses | 4.33925 | 3.04647 | 2.53359 | 1.76616 | 1.22565 |
Total Assets | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
Property/Plant/Equipment, Total - Net | 58.1977 | 45.8523 | 33.1413 | 30.1157 | 30.4669 |
Property/Plant/Equipment, Total - Gross | 71.4696 | 54.7162 | 38.8663 | 33.5368 | 31.7528 |
Accumulated Depreciation, Total | -13.2718 | -8.86394 | -5.72496 | -3.42103 | -1.28592 |
Other Long Term Assets, Total | 4.0674 | 2.10698 | 1.44004 | 6.69725 | 6.83155 |
Total Current Liabilities | 30.3783 | 19.9474 | 14.0279 | 9.62505 | 9.44018 |
Accounts Payable | 12.4294 | 11.0737 | 9.17459 | 5.90039 | 5.92087 |
Accrued Expenses | 16.7941 | 8.73083 | 4.71047 | 3.58182 | 3.37648 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 1.15482 | 0.14283 | 0.14283 | 0.14283 | 0.14283 |
Total Liabilities | 135.08 | 119.424 | 100.898 | 69.1061 | 67.6861 |
Total Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
Long Term Debt | 94.8662 | 92.9689 | 83.1992 | 44.075 | 42.9709 |
Other Liabilities, Total | 9.8356 | 6.50774 | 3.67047 | 15.406 | 15.275 |
Total Equity | 141.173 | 88.2494 | 26.1931 | 19.7704 | 40.3328 |
Common Stock | 0.01958 | 0.01049 | 0.00593 | 0.00464 | 0.00453 |
Additional Paid-In Capital | 553.266 | 428.704 | 290.904 | 236.203 | 191.022 |
Retained Earnings (Accumulated Deficit) | -412.113 | -340.465 | -264.717 | -216.437 | -150.694 |
Total Liabilities & Shareholders’ Equity | 276.253 | 207.673 | 127.091 | 88.8765 | 108.019 |
Total Common Shares Outstanding | 195.814 | 104.903 | 59.3184 | 46.3531 | 36.7255 |
Other Current Assets, Total | 0 | 1.5 | |||
Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
Intangibles, Net | 1.72877 | 2.44412 | 3.15947 | 4.00441 | 4.84935 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 239.8 | 208.729 | 174.785 | 171.355 | 177.277 |
Efectivo e inversiones a corto plazo | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
Efectivo y Equivalentes | 69.505 | 51.0891 | 34.4106 | 42.409 | 61.9657 |
Total deudores, neto | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
Accounts Receivable - Trade, Net | 25.6296 | 28.5769 | 20.3926 | 23.5446 | 15.362 |
Total Inventory | 139.146 | 124.724 | 114.123 | 99.6997 | 94.1462 |
Prepaid Expenses | 5.5193 | 4.33925 | 5.85905 | 5.70186 | 5.80261 |
Total Assets | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
Property/Plant/Equipment, Total - Net | 60.3271 | 58.1977 | 55.0847 | 53.316 | 50.3729 |
Property/Plant/Equipment, Total - Gross | 75.0076 | 71.4696 | 67.2809 | 64.2715 | 60.2769 |
Accumulated Depreciation, Total | -14.6804 | -13.2718 | -12.1962 | -10.9555 | -9.90401 |
Goodwill, Net | 3.52951 | 3.52951 | 3.52951 | 3.52951 | 3.52951 |
Intangibles, Net | 1.54993 | 1.72877 | 1.90761 | 2.08645 | 2.26528 |
Other Long Term Assets, Total | 2.82575 | 4.0674 | 3.33351 | 2.52666 | 2.22278 |
Total Current Liabilities | 31.5665 | 30.3783 | 32.3372 | 18.1864 | 21.2057 |
Accounts Payable | 14.1151 | 12.4294 | 17.2828 | 6.16747 | 12.1529 |
Accrued Expenses | 14.2198 | 16.7941 | 13.0301 | 10.7303 | 8.14151 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 3.23159 | 1.15482 | 2.02432 | 1.28866 | 0.91137 |
Total Liabilities | 181.099 | 135.08 | 135.86 | 121.22 | 123.163 |
Total Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
Long Term Debt | 138.423 | 94.8662 | 94.363 | 93.877 | 93.4127 |
Other Liabilities, Total | 11.1099 | 9.8356 | 9.15999 | 9.15685 | 8.54454 |
Total Equity | 126.933 | 141.173 | 102.78 | 111.594 | 112.504 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.01964 | 0.01958 | 0.01383 | 0.01319 | 0.0123 |
Additional Paid-In Capital | 564.034 | 553.266 | 498.23 | 489.331 | 471.337 |
Retained Earnings (Accumulated Deficit) | -437.121 | -412.113 | -395.463 | -377.75 | -358.845 |
Total Liabilities & Shareholders’ Equity | 308.033 | 276.253 | 238.64 | 232.814 | 235.667 |
Total Common Shares Outstanding | 196.348 | 195.814 | 138.314 | 131.872 | 123.045 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -71.6476 | -75.7486 | -48.2793 | -65.7434 | -43.759 |
Efectivo de actividades de explotación | -112.369 | -102.003 | -76.1935 | -62.6787 | -37.2718 |
Efectivo de actividades de explotación | 5.4955 | 3.94229 | 3.25815 | 3.4464 | 2.6923 |
Partidas no monetarias | 5.46355 | 3.58462 | 2.33044 | 3.30681 | 4.07714 |
Intereses pagados en efectivo | 11.1595 | 10.2676 | 8.11223 | 4.39997 | 2.29359 |
Cambios en el capital circulante | -51.6804 | -33.7813 | -33.5028 | -3.68844 | -0.28224 |
Efectivo de actividades de inversión | -13.5113 | -12.7247 | -3.81184 | -2.0956 | 15.2139 |
Gastos de capital | -13.5113 | -12.7267 | -3.81184 | -2.0956 | -2.67633 |
Otras partidas de flujo de caja de inversión, total | 0 | 0.002 | 0 | 17.8902 | |
Efectivo procedente de actividades de financiación | 121.048 | 143.897 | 80.0026 | 42.9216 | 60.7506 |
Elementos de flujo de caja de financiación | -0.0616 | -0.83 | -10.9395 | 0 | -3.44017 |
Emisión (retiro) de acciones, neto | 121.144 | 131.209 | 48.4721 | 42.9578 | 39.2074 |
Emisión (amortización) de deuda, neta | -0.0343 | 13.5179 | 42.47 | -0.03628 | 24.9834 |
Variación neta de la tesorería | -4.83203 | 29.169 | -0.00272 | -21.8527 | 38.6927 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -25.0079 | -71.6476 | -54.9982 | -37.2852 | -18.3799 |
Cash From Operating Activities | -26.0134 | -112.369 | -78.9037 | -65.4914 | -33.2291 |
Cash From Operating Activities | 1.59022 | 5.4955 | 3.97779 | 2.55562 | 1.22963 |
Non-Cash Items | 8.86246 | 5.46355 | 3.64236 | 2.50146 | 1.19026 |
Cash Interest Paid | 2.52599 | 11.1595 | 8.34697 | 5.53428 | 2.75196 |
Changes in Working Capital | -11.4582 | -51.6804 | -31.5257 | -33.2632 | -17.2691 |
Cash From Investing Activities | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
Capital Expenditures | -2.84209 | -13.5113 | -9.8354 | -7.04674 | -2.57116 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | 47.2713 | 121.048 | 67.2286 | 59.0259 | 41.8448 |
Financing Cash Flow Items | -4.46973 | -0.0616 | -0.0616 | -0.05931 | -0.05931 |
Issuance (Retirement) of Stock, Net | 0 | 121.144 | 67.3157 | 59.1021 | 41.9125 |
Issuance (Retirement) of Debt, Net | 51.7411 | -0.0343 | -0.02551 | -0.01686 | -0.00836 |
Net Change in Cash | 18.4158 | -4.83203 | -21.5106 | -13.5122 | 6.04456 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.0714 | 13488055 | 1946140 | 2022-12-31 | LOW |
Perceptive Advisors LLC | Private Equity | 5.3567 | 11900255 | 966868 | 2022-12-31 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.9547 | 11007209 | 1583787 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.8776 | 10835875 | 1545176 | 2022-12-31 | LOW |
NWQ Investment Management Company, LLC | Investment Advisor/Hedge Fund | 4.7771 | 10612600 | 3727960 | 2021-12-31 | LOW |
D. E. Shaw & Co., L.P. | Hedge Fund | 3.8299 | 8508409 | 2664613 | 2022-12-31 | MED |
Stonepine Capital Management, LLC | Investment Advisor/Hedge Fund | 3.1239 | 6940000 | 1940000 | 2022-12-31 | MED |
Magnetar Capital Partners LP | Investment Advisor/Hedge Fund | 2.7851 | 6187316 | 1815908 | 2022-12-31 | HIGH |
AWM Investment Company, Inc. | Investment Advisor/Hedge Fund | 2.7076 | 6015000 | 1000000 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 2.3843 | 5296781 | 3569778 | 2022-12-31 | HIGH |
Nuveen Asset Management, LLC | Investment Advisor/Hedge Fund | 1.8471 | 4103514 | -883582 | 2022-12-31 | LOW |
Velan Capital Investment Management LP | Investment Advisor/Hedge Fund | 1.8005 | 4000000 | -1269155 | 2022-12-31 | MED |
Invesco Advisers, Inc. | Investment Advisor | 1.7531 | 3894678 | 813693 | 2022-12-31 | LOW |
Aisling Capital, LLC | Private Equity | 1.6275 | 3615671 | 0 | 2022-04-15 | |
Nuveen LLC | Pension Fund | 1.5525 | 3448993 | -267644 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5245 | 3386852 | 100723 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.337 | 2970124 | 1530127 | 2022-12-31 | HIGH |
Altium Capital Management LP | Investment Advisor/Hedge Fund | 1.2919 | 2870000 | -13710 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 1.2702 | 2821903 | 558990 | 2022-12-31 | MED |
Caligan Partners, LP | Hedge Fund | 1.2046 | 2676093 | -8217144 | 2022-12-31 | MED |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ADMA Biologics, Inc. Company profile
Sobre ADMA Biologics Inc
ADMA Biologics, Inc. es una empresa biofarmacéutica. Desarrolla, fabrica y comercializa productos biológicos especializados basados en plasma para el tratamiento y la prevención de enfermedades infecciosas. Se dedica al desarrollo y la comercialización de plasma humano y productos terapéuticos derivados del plasma. Entre sus pacientes se encuentran individuos inmunocomprometidos que sufren un trastorno de inmunodeficiencia subyacente e inmunodeprimidos por razones médicas. Sus productos candidatos incluyen BIVIGAM, un producto de inmunoglobulina intravenosa (IGIV) indicado para el tratamiento de la inmunodeficiencia humoral primaria (IP); ASCENIV un producto de IGIV indicado para el tratamiento de la IP, y Nabi-HB que está indicado para el tratamiento de la exposición aguda a la sangre que contiene el antígeno de superficie de la hepatitis B (HBsAg). Su filial ADMA BioCenters gestiona instalaciones de recogida de plasma en los Estados Unidos. Su segmento de Centros de Recogida de Plasma, proporciona una parte de su plasma sanguíneo para la fabricación de sus productos candidatos.
Industry: | Biopharmaceuticals |
C/O Adma Biologics, Inc.
465 State Route 17
RAMSEY
NEW JERSEY 07446
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com